A new report trying to settle a decades-old debate about Alzheimer’s disease has reached a dramatic conclusion: Antibody drugs that target sticky amyloid beta proteins

Roche said it will run a new Phase 3 trial for the controversial Duchenne muscular dystrophy gene therapy Elevidys in another attempt to win approval

💰 MeiraGTx buys back eye gene therapy from J&J for just $25M: The gene therapy, known as bota-vec, failed a Phase 3 study for X-linked

A new Apposite Capital fund has been set up with £100m to provide much-needed scale-up funding for UK biopharma and healthtech companies.

As the prices paid for priority review vouchers (PRVs) have crept up over the past year — the last two have sold for at least